(Q37577869)

21 August 2017

1 reference

title

Comparative tolerability of newer agents for insomnia (English)

1 reference

21 August 2017

0 references

Gary Zammit

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

32

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

735-748

1 reference

https://scigraph.springernature.com/pub.10.2165/11312920-000000000-00000

21 August 2017

exact match

0 references

cites work

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Nonbenzodiazepine hypnotic use and cases of "sleep driving".

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Compulsive activity and anterograde amnesia after zolpidem use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11312920-000000000-00000

Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices

21 January 2018

1 reference

12 December 2020

Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots.

1 reference

12 December 2020

Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.

1 reference

12 December 2020

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

1 reference

12 December 2020

Dose response effects of zolpidem in normal geriatric subjects.

1 reference

12 December 2020

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

1 reference

12 December 2020

Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

1 reference

12 December 2020

The abuse potential of zolpidem administered alone and with alcohol

1 reference

12 December 2020

Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.

1 reference

12 December 2020

The safety and tolerability of zolpidem--an update

1 reference

12 December 2020

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

1 reference

12 December 2020

Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated unsomniacs

1 reference

12 December 2020

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

1 reference

12 December 2020

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia

1 reference

12 December 2020

Zolpidem and amnestic sleep related eating disorder.

1 reference

12 December 2020

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

1 reference

12 December 2020

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

1 reference

12 December 2020

Triazolam and zolpidem: effects on human memory and attentional processes

1 reference

12 December 2020

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

1 reference

12 December 2020

Sleep in the Elderly: Burden, Diagnosis, and Treatment

1 reference

12 December 2020

Chronic administration of zopiclone and nitrazepam in the treatment of insomnia.

1 reference

12 December 2020

Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.

1 reference

12 December 2020

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia

1 reference

12 December 2020

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

1 reference

12 December 2020

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

1 reference

12 December 2020

A postmarketing study of relative abuse liability of hypnotic sedative drugs

1 reference

12 December 2020

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter stu

1 reference

12 December 2020

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

1 reference

12 December 2020

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

1 reference

12 December 2020

Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task

1 reference

12 December 2020

Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.

1 reference

12 December 2020

Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.

1 reference

12 December 2020

Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects

1 reference

12 December 2020

The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study

1 reference

12 December 2020

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

1 reference

12 December 2020

Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers

1 reference

12 December 2020

Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test

1 reference

12 December 2020

Zolpidem-induced sleep-driving

1 reference

12 December 2020

Hypnosedative-induced complex behaviours : incidence, mechanisms and management

1 reference

12 December 2020

Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol

1 reference

12 December 2020

Eszopiclone (Lunesta), a new hypnotic

1 reference

12 December 2020

Comparison of the Reinforcing Properties of Zopiclone and Triazolam in Former Alcoholics

1 reference

12 December 2020

Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

1 reference

12 December 2020

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

1 reference

12 December 2020

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

1 reference

12 December 2020

Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

1 reference

12 December 2020

Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.

1 reference

12 December 2020

Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia.

1 reference

12 December 2020

A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia.

1 reference

12 December 2020

Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone

1 reference

12 December 2020

A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients

1 reference

12 December 2020

Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment

1 reference

12 December 2020

The effect of zolpidem and zopiclone on memory.

1 reference

12 December 2020

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

1 reference

12 December 2020

Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients

1 reference

12 December 2020

Rifampin reduces plasma concentrations and effects of zolpidem.

1 reference

12 December 2020

Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.

1 reference

12 December 2020

A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.

1 reference

12 December 2020

Comparative efficacy of zolpidem and temazepam in transient insomnia.

1 reference

12 December 2020

Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent.

1 reference

12 December 2020

Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.

1 reference

12 December 2020

Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

1 reference

12 December 2020

Sedative, memory, and performance effects of hypnotics.

1 reference

12 December 2020

Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone

1 reference

12 December 2020

Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic

1 reference

12 December 2020

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

1 reference

12 December 2020

Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons

1 reference

12 December 2020

A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers

1 reference

12 December 2020

Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers

1 reference

12 December 2020

Coadministration of short-term zolpidem with sertraline in healthy women

1 reference

12 December 2020

A polysomnography study of eszopiclone in elderly patients with insomnia.

1 reference

12 December 2020

Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.

1 reference

12 December 2020

Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.

1 reference

12 December 2020

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

1 reference

12 December 2020

Prolonged coma after eszopiclone overdose

1 reference

12 December 2020

Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons

1 reference

12 December 2020

A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia

1 reference

12 December 2020

Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Effects of zaleplon or triazolam with or without ethanol on human performance.

1 reference

12 December 2020

Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia

1 reference

12 December 2020

Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m.

1 reference

12 December 2020

Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

1 reference

12 December 2020

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia

1 reference

12 December 2020

Selective effects of zolpidem on human memory functions

1 reference

12 December 2020

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

1 reference

12 December 2020

Amnestic sleep-related eating disorder associated with zolpidem

1 reference

12 December 2020

Epidemiological evidence for a low abuse potential of zolpidem

1 reference

12 December 2020

Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal

1 reference

12 December 2020

Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.

1 reference

12 December 2020

Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases.

1 reference

12 December 2020

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole

1 reference

12 December 2020

Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.

1 reference

12 December 2020

An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults

1 reference

12 December 2020

A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.

1 reference

12 December 2020

Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds

1 reference

12 December 2020

The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice

1 reference

12 December 2020

Zolpidem for persistent insomnia in SSRI-treated depressed patients

1 reference

12 December 2020

The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.

1 reference

12 December 2020

Psychomotor effects of zaleplon and thioridazine coadministration

1 reference

12 December 2020

A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

1 reference

12 December 2020

10.2165/11312920-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1005800789

0 references

1 reference